**Question:** The following statements regarding H2 receptor antagonist are true except:

A. H2 receptor antagonists are used in the treatment of peptic ulcer disease.
B. H2 receptor antagonists reduce gastric acid secretion by blocking histamine H2 receptors on the parietal cells in the stomach.
C. H2 receptor antagonists are contraindicated in patients with a history of angioedema.
D. H2 receptor antagonists are more effective than proton pump inhibitors in reducing gastric acid secretion.

**Correct Answer:** D. H2 receptor antagonists are more effective than proton pump inhibitors in reducing gastric acid secretion.

**Core Concept:** H2 receptor antagonists are drugs that block histamine H2 receptors on the parietal cells in the stomach. This leads to reduced gastric acid secretion, which is beneficial in conditions like peptic ulcer disease. Proton pump inhibitors (PPIs) are a class of drugs that inhibit the enzyme responsible for producing gastric acid (H+/K+-ATPase) directly, making them more potent than H2 receptor antagonists in reducing gastric acid secretion.

**Why the Correct Answer is Right:**

H2 receptor antagonists (e.g., cimetidine, ranitidine) work by blocking histamine (H2) receptors on the parietal cells in the stomach. This leads to a decrease in gastric acid secretion, which is beneficial in conditions like peptic ulcer disease, where excess gastric acid production contributes to the development and perpetuation of ulcers.

**Why Option D is Incorrect:**

While H2 receptor antagonists do reduce gastric acid secretion, they are less potent than proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and rabeprazole. Proton pump inhibitors directly inhibit the enzyme responsible for producing gastric acid (H+/K+-ATPase), resulting in a more significant decrease in gastric acid secretion compared to H2 receptor antagonists. Because of this difference in mechanism of action, proton pump inhibitors are generally considered more effective in reducing gastric acid secretion than H2 receptor antagonists.

**Why Options A and C are Correct:**

Option A is correct as H2 receptor antagonists are primarily used in the treatment of peptic ulcer disease and gastroesophageal reflux disease (GERD).

Option C is correct because some patients with a history of angioedema or those receiving ACE inhibitors may experience angioedema due to the increased release of bradykinin, which can lead to swelling and other adverse reactions, although this is relatively rare.

**Why Option B is Incorrect:**

Option B is incorrect because proton pump inhibitors are more effective in reducing gastric acid secretion than H2 receptor antagonists. While both classes of drugs can be used for similar purposes, proton pump inhibitors are generally considered more potent and effective in reducing gastric acid secretion.

**Clinical Pearls:**

1. H2 receptor antagonists and proton pump inhibitors have overlapping indications in treating conditions like peptic ulcer disease, GERD, and gastritis.
2. Although both drug classes can be considered safe in patients taking ACE inhibitors, proton pump inhibitors are preferred due to their stronger acid-supp